Vaccine submission with muscle electroporation

Vaccine

Volumn 26, Issue 15, 2008, Pages 1805-1806

  Yuan, Ti Fei ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

DNA vaccine; Electroporation; Gene therapy; Muscle; Vaccine

Indexed keywords

DNA VACCINE;

DRUG POTENCY; ELECTROPORATION; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; LETTER; MUSCLE; PRIORITY JOURNAL; VACCINE PRODUCTION;

ANIMALS; ELECTROPORATION; HUMANS; MUSCLES; VACCINATION; VACCINES, DNA;

EID: 40849135487     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.047     Document Type: Letter

References (19)

1. Andreason G.L., and Evans G.A. Optimization of electroporation for transfection of mammalian cell lines. Anal Biochem 180 (1989) 269-275
2. Babiuk L.A., Pontarollo R., Babiuk S., Loehr B., and van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 (2003) 649-658
3. Bureau M.F., Gehl J., Deleuze V., Mir L.M., and Scherman D. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 1474 (2000) 353-359
4. Fattori E., La Monica N., Ciliberto G., and Toniatti C. Electro-gene-transfer: a new approach for muscle gene delivery. Somat Cell Mol Genet 27 (2002) 75-83
5. Isaka Y., and Imai E. Electroporation-mediated gene therapy. Expert Opin Drug Deliv 4 (2007) 561-571
6. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 64 (1999) 508-514
7. Monath T.P., Liu J., Kanesa-Thasan N., Myers G.A., Nichols R., Deary A., et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A 103 (2006) 6694-6699
8. Neumann E., Kakorin S., and Toensing K. Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 48 (1999) 3-16
9. Otten G., Schaefer M., Doe B., Liu H., Srivastava I., zur Megede J., et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22 (2004) 2489-2493
10. Scheerlinck J.P., Karlis J., Tjelle T.E., Presidente P.J., Mathiesen I., and Newton S.E. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22 (2004) 1820-1825
11. Selby M., Goldbeck C., Pertile T., Walsh R., and Ulmer J. Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol 83 (2000) 147-152
12. Sukharev S.I., Klenchin V.A., Serov S.M., Chernomordik L.V., and Chizmaszhev Y.A. Electroporation and electrophoretic DNA transfer into cells: the effect of DNA interaction with electropores. Biophys J 63 (1992) 1320-1327
13. Svensson E.C., Tripathy S.K., and Leiden J.M. Muscle-based gene therapy: realistic possibilities for the future. Mol Med Today 2 (1996) 166-172
14. Tjelle T.E., Salte R., Mathiesen I., and Kjeken R. A novel electroporation device for gene delivery in large animal and humans. Vaccine 24 (2006) 4667-4670
15. Weaver J.C., and Chizmadzhev Y.A. Theory of electroporation: a review. Bioelectrochem Bioenerg 41 (1996) 135-160
16. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 (2000) 4635-4640
17. Wu C.J., Lee S.C., Huang H.W., and Tao M.H. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 22 (2004) 1457-1464
18. Yuan T.F. Electroporation: an arsenal of application. Cytotechnology 54 (2007) 71-76
19. zur Megede J., Otten G.R., Doe B., Liu H., Srivastava R., Greer C., et al. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines. Vaccine 24 (2006) 2755-2763